| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2004;109:1745-1749.)
© 2004 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Department of Medicine, Duke University Medical Center, Durham, NC.
Correspondence to Andrew Wang, MD, DUMC Box 3428, Durham, NC 27710. E-mail a.wang{at}duke.edu
Received August 22, 2003; de novo received October 13, 2003; revision received January 13, 2004; accepted January 14, 2004.
Background Data on early determinants of outcome in infective endocarditis (IE) are limited. We evaluated the prognostic significance of early clinical characteristics in a large, prospective cohort of patients with IE.
Methods and Results Two hundred sixty-seven consecutive patients with definite or possible IE by modified Duke criteria and echocardiography performed within 7 days of presentation were evaluated. Acute physiology was assessed by the Acute Physiology, Age, Chronic Health Evaluation II (APACHE II) score at the time of presentation, and early heart failure was diagnosed by Framingham criteria. In-hospital mortality rate in the cohort was 19% and similar for patients with definite or possible IE (20% versus 16%, respectively; P=0.464). Independent predictors of death determined by logistic regression modeling were diabetes mellitus (OR 2.48; 95% CI, 1.24 to 4.96), Staphylococcus aureus as causative organism (OR, 2.06; 95% CI, 1.01 to 4.20), APACHE II score (OR, 1.07; 95% CI, 1.01 to 1.12), and embolic event (OR, 2.79; 95% CI, 1.15 to 6.80). Early echocardiographic findings of the Duke criteria were not predictive of death.
Conclusions Early in the course of IE, readily available clinical characteristics that reflect the host-pathogen interaction are predictive of in-hospital death. These factors may identify those patients with IE for more aggressive treatment.
Key Words: endocardium prognosis infection valves echocardiography
This article has been cited by other articles:
![]() |
G. Nadji, D. Rusinaru, J.-P. Remadi, A. Jeu, C. Sorel, and C. Tribouilloy Heart failure in left-sided native valve infective endocarditis: characteristics, prognosis, and results of surgical treatment Eur J Heart Fail, July 1, 2009; 11(7): 668 - 675. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Sy, C. Chawantanpipat, D. R. Richmond, and L. Kritharides Development and validation of a time-dependent risk model for predicting mortality in infective endocarditis Eur. Heart J., March 28, 2009; (2009) ehp085v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Duarte Rodriguez Bioprosthetic Aortic Valve Infective Endocarditis Journal of Diagnostic Medical Sonography, March 1, 2009; 25(2): 116 - 120. [Abstract] [PDF] |
||||
![]() |
A. Bannay, B. Hoen, X. Duval, J.-F. Obadia, C. Selton-Suty, V. Le Moing, P. Tattevin, B. Iung, F. Delahaye, F. Alla, et al. The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results? Eur. Heart J., February 9, 2009; (2009) ehp008v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Warnes, R. G. Williams, T. M. Bashore, J. S. Child, H. M. Connolly, J. A. Dearani, P. del Nido, J. W. Fasules, T. P. Graham Jr, Z. M. Hijazi, et al. ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease) Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J. Am. Coll. Cardiol., December 2, 2008; 52(23): e143 - e263. [Full Text] [PDF] |
||||
![]() |
C. A. Warnes, R. G. Williams, T. M. Bashore, J. S. Child, H. M. Connolly, J. A. Dearani, P. del Nido, J. W. Fasules, T. P. Graham Jr, Z. M. Hijazi, et al. ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease): Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation, December 2, 2008; 118(23): e714 - e833. [Full Text] [PDF] |
||||
![]() |
C. A. Warnes, R. G. Williams, T. M. Bashore, J. S. Child, H. M. Connolly, J. A. Dearani, P. del Nido, J. W. Fasules, T. P. Graham Jr, Z. M. Hijazi, et al. ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Adults With Congenital Heart Disease): Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation, December 2, 2008; 118(23): 2395 - 2451. [Full Text] [PDF] |
||||
![]() |
E. Durante-Mangoni, S. Bradley, C. Selton-Suty, M.-F. Tripodi, B. Barsic, E. Bouza, C. H. Cabell, A. I. d. O. Ramos, V. Fowler Jr, B. Hoen, et al. Current Features of Infective Endocarditis in Elderly Patients: Results of the International Collaboration on Endocarditis Prospective Cohort Study Arch Intern Med, October 27, 2008; 168(19): 2095 - 2103. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Saito, N. Motomura, K. Kakimi, K. Narui, N. Noguchi, M. Sasatsu, K. Kubo, Y. Koezuka, D. Takai, S. Ueha, et al. Vascular allografts are resistant to methicillin-resistant Staphylococcus aureus through indoleamine 2,3-dioxygenase in a murine model J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 159 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Shroff, M. Skeans, and C. A. Herzog Outcomes of renal transplant and waiting list patients with bacterial endocarditis in the United States Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2381 - 2385. [Abstract] [Full Text] [PDF] |
||||
![]() |
I M Tleyjeh, J M Steckelberg, G Georgescu, H M K Ghomrawi, T L Hoskin, F B Enders, F Mookadam, W C Huskins, W R Wilson, and L M Baddour The association between the timing of valve surgery and 6-month mortality in left-sided infective endocarditis Heart, July 1, 2008; 94(7): 892 - 896. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Sy, C. Chawantanpipat, D. R. Richmond, and L. Kritharides Thrombocytopenia and Mortality in Infective Endocarditis J. Am. Coll. Cardiol., May 6, 2008; 51(18): 1824 - 1825. [Full Text] [PDF] |
||||
![]() |
E. E. Hill, M.-C. Herregods, S. Vanderschueren, P. Claus, W. E. Peetermans, and P. Herijgers Outcome of Patients Requiring Valve Surgery During Active Infective Endocarditis Ann. Thorac. Surg., May 1, 2008; 85(5): 1564 - 1569. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Liao, D F Kong, Z Samad, P A Pappas, J G Jollis, S S Lin, A Wang, V G Fowler Jr, V H Chu, D J Sexton, et al. Echocardiographic risk stratification for early surgery with endocarditis: a cost-effectiveness analysis Heart, May 1, 2008; 94(5): e18 - e18. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. K. Nandigam, I . Klein, B . Iung, M . Wolff, E . Brochet, P . Longuet, J .-P. Laissy, and X . Duval SILENT T2* CEREBRAL MICROBLEEDS: A POTENTIAL NEW IMAGING CLUE IN INFECTIVE ENDOCARDITIS Neurology, January 22, 2008; 70(4): 323 - 324. [Full Text] [PDF] |
||||
![]() |
M. S. Slater, C. B. Komanapalli, U. Tripathy, P. S. Ravichandran, and R. M. Ungerleider Treatment of Endocarditis: A Decade of Experience Ann. Thorac. Surg., June 1, 2007; 83(6): 2074 - 2080. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Remadi, G. Habib, G. Nadji, A. Brahim, F. Thuny, J. P. Casalta, M. Peltier, and C. Tribouilloy Predictors of Death and Impact of Surgery in Staphylococcus aureus Infective Endocarditis Ann. Thorac. Surg., April 1, 2007; 83(4): 1295 - 1302. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wang, E. Athan, P. A. Pappas, V. G. Fowler Jr, L. Olaison, C. Pare, B. Almirante, P. Munoz, M. Rizzi, C. Naber, et al. Contemporary Clinical Profile and Outcome of Prosthetic Valve Endocarditis JAMA, March 28, 2007; 297(12): 1354 - 1361. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Seto The Case for Infectious Endocarditis Prophylaxis: Time to Move Forward Arch Intern Med, February 26, 2007; 167(4): 327 - 330. [Full Text] [PDF] |
||||
![]() |
D. S. Jassal, T. G. Neilan, A. D. Pradhan, K. E. Lynch, G. Vlahakes, A. K. Agnihotri, and M. H. Picard Surgical Management of Infective Endocarditis: Early Predictors of Short-Term Morbidity and Mortality Ann. Thorac. Surg., August 1, 2006; 82(2): 524 - 529. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Gammie, S. M. O'Brien, B. P. Griffith, and E. D. Peterson Surgical Treatment of Mitral Valve Endocarditis in North America Ann. Thorac. Surg., December 1, 2005; 80(6): 2199 - 2204. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Adachi, J. Kobayashi, H. Nakajima, K. Niwaya, H. Ishibashi-Ueda, K. Bando, and O. Tagusari Coronary Embolism and Subsequent Myocardial Abscess Complicating Ventricular Aneurysm and Tachycardia Ann. Thorac. Surg., December 1, 2005; 80(6): 2366 - 2368. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Thuny, G. Disalvo, O. Belliard, J.-F. Avierinos, V. Pergola, V. Rosenberg, J.-P. Casalta, J. Gouvernet, G. Derumeaux, D. Iarussi, et al. Risk of Embolism and Death in Infective Endocarditis: Prognostic Value of Echocardiography: A Prospective Multicenter Study Circulation, July 5, 2005; 112(1): 69 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Nadji, J P Remadi, F Coviaux, A Ali Mirode, A Brahim, M Enriquez-Sarano, and C Tribouilloy Comparison of clinical and morphological characteristics of Staphylococcus aureus endocarditis with endocarditis caused by other pathogens Heart, July 1, 2005; 91(7): 932 - 937. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Baddour, W. R. Wilson, A. S. Bayer, V. G. Fowler Jr, A. F. Bolger, M. E. Levison, P. Ferrieri, M. A. Gerber, L. Y. Tani, M. H. Gewitz, et al. Infective Endocarditis: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America Circulation, June 14, 2005; 111(23): e394 - e434. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Peters Infective Endocarditis Journal of Diagnostic Medical Sonography, May 1, 2005; 21(3): 192 - 204. [Abstract] [PDF] |
||||
![]() |
S. H. Rahimtoola The year in valvular heart disease J. Am. Coll. Cardiol., January 4, 2005; 45(1): 111 - 122. [Full Text] [PDF] |
||||
![]() |
C. L. Thompson, K. C. Dunn, M. C. Menon, L. E. Kearns, and S. S. Braithwaite Hyperglycemia in the Hospital Diabetes Spectr, January 1, 2005; 18(1): 20 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Moreno, A. Villate, C. Macaya, V. H. Chu, C. H. Cabell, D. K. Benjamin Jr, E. F. Kuniholm, V. G. Fowler, J. Engemann, D. J. Sexton, et al. Infective Endocarditis: Should Diabetic Patients Be Treated More Aggressively? * Response Circulation, August 17, 2004; 110(7): e72 - e72. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |